FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to medicine and pharmacy. Disclosed is use of i) uridine and/or equivalent selected from a group consisting of deoxyuridine, uridine phosphate, uracil nucleic base and/or acylated derivatives of uridine and/or esters and (ii) n-3 polyunsaturated fatty acids (PUFA) for producing a composition for restoring or improving urinary bladder function in a subject having an impaired bladder function and wherein the subject is a patient suffering, recovering from, and/or suffered a neurological disorder and a corresponding method of treating said disorder.
EFFECT: technical result consists in reduction (from 12 to 2 days) of recovery of urinary bladder reflex capacity to emptying on a model of statistical compression of spinal cord at level T12 of thoracic spine.
21 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2749191C2 |
METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2622999C2 |
METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY | 2013 |
|
RU2667968C2 |
TREATMENT OF TRAUMATIC BRAIN INJURY | 2018 |
|
RU2771277C2 |
COMBINATION OF COMPONENTS FOR PREVENTION AND TREATMENT OF INDISPOSITION | 2011 |
|
RU2646830C2 |
METHOD FOR CONTROL FUNCTIONS IMPROVEMENT | 2012 |
|
RU2637089C2 |
NUTRITIVE PRODUCT FOR REDUCING PHENYLALANINE LEVELS IN THE PATIENTS WITH PKU | 2016 |
|
RU2740905C2 |
RECOGNITION IMPROVEMENT | 2012 |
|
RU2638809C2 |
FOOD COMPOSITION FOR PATIENTS SUFFERING FROM PRODROMAL DEMENTIA | 2008 |
|
RU2487557C2 |
NON-MEDICAL INCREASE OR MAINTENANCE OF BODY WEIGHT OF A MAMMAL | 2011 |
|
RU2647461C2 |
Authors
Dates
2020-02-26—Published
2016-03-15—Filed